abstract |
The present invention describes a hexameric complex of insulin analogues and formulations. More specifically, the present invention relates to various parenteral formulations which include: analogues of human insulin in a hexameric conformation, zinc ions and at least three molecules of a phenolic derivative selected from the group consisting of m cresol, phenol or a mixture of m cresol and phenol. The wording provides a quick start to action. |